Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
UBR1
Introduction
The human gene UBR1 encodes the enzyme ubiquitin-protein ligase E3 component n-recognin 1.[1][2]
The N-end rule pathway is one proteolytic pathway of the ubiquitin system. The recognition component of this pathway, encoded by this gene, binds to a destabilizing N-terminal residue of a substrate protein and participates in the formation of a substrate-linked multiubiquitin chain. This leads to the eventual degradation of the substrate protein. The protein described in this record has a RING-type zinc finger and a UBR-type zinc finger. Mutations in this gene have been associated with Johanson-Blizzard syndrome.[2]
References
References
- ↑ Kwon YT, Reiss Y, Fried VA, Hershko A, Yoon JK, Gonda DK, Sangan P, Copeland NG, Jenkins NA, Varshavsky A (Aug 1998). “The mouse and human genes encoding the recognition component of the N-end rule pathway”. Proc Natl Acad Sci U S A. 95 (14): 7898–903. doi:10.1073/pnas.95.14.7898. PMC 20901. PMID 9653112.
- ↑ 2.0 2.1 “Entrez Gene: UBR1 ubiquitin protein ligase E3 component n-recognin 1”.
Further reading
Further reading
- Varshavsky A (1996). “The N-end rule: functions, mysteries, uses”. Proc. Natl. Acad. Sci. U.S.A. 93 (22): 12142–9. doi:10.1073/pnas.93.22.12142. PMC 37957. PMID 8901547.
- Chiannilkulchai N, Pasturaud P, Richard I, et al. (1995). “A primary expression map of the chromosome 15q15 region containing the recessive form of limb-girdle muscular dystrophy (LGMD2A) gene”. Hum. Mol. Genet. 4 (4): 717–25. doi:10.1093/hmg/4.4.717. PMID 7633422.
- Dgany O, Avidan N, Delaunay J, et al. (2003). “Congenital Dyserythropoietic Anemia Type I Is Caused by Mutations in Codanin-1”. Am. J. Hum. Genet. 71 (6): 1467–74. doi:10.1086/344781. PMC 378595. PMID 12434312.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Yin J, Kwon YT, Varshavsky A, Wang W (2005). “RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway”. Hum. Mol. Genet. 13 (20): 2421–30. doi:10.1093/hmg/ddh269. PMID 15317757.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Kwak KS, Zhou X, Solomon V, et al. (2005). “Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia”. Cancer Res. 64 (22): 8193–8. doi:10.1158/0008-5472.CAN-04-2102. PMID 15548684.
- Tasaki T, Mulder LC, Iwamatsu A, et al. (2005). “A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons”. Mol. Cell. Biol. 25 (16): 7120–36. doi:10.1128/MCB.25.16.7120-7136.2005. PMC 1190250. PMID 16055722.
- Stelzl U, Worm U, Lalowski M, et al. (2005). “A human protein-protein interaction network: a resource for annotating the proteome”. Cell. 122 (6): 957–68. doi:10.1016/j.cell.2005.08.029. PMID 16169070.
- Zenker M, Mayerle J, Lerch MM, et al. (2006). “Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome)”. Nat. Genet. 37 (12): 1345–50. doi:10.1038/ng1681. PMID 16311597.
- Sasaki T, Kojima H, Kishimoto R, et al. (2006). “Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role”. Mol. Cell. 24 (1): 63–75. doi:10.1016/j.molcel.2006.08.005. PMID 17018293.
- Zou W, Wang J, Zhang DE (2007). “Negative Regulation of ISG15 E3 ligase EFP through its autoISGylation”. Biochem. Biophys. Res. Commun. 354 (1): 321–7. doi:10.1016/j.bbrc.2006.12.210. PMC 1858649. PMID 17222803.
- Sakane A, Hatakeyama S, Sasaki T (2007). “Involvement of Rabring7 in EGF receptor degradation as an E3 ligase”. Biochem. Biophys. Res. Commun. 357 (4): 1058–64. doi:10.1016/j.bbrc.2007.04.052. PMID 17462600.
- Wei S, Lin LF, Yang CC, et al. (2007). “Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma”. Mol. Pharmacol. 72 (3): 725–33. doi:10.1124/mol.107.035287. PMID 17569795.